Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Another boost for stem cell research

16.11.2006
In the wake of the Senate’s decision to pass the human embryo cloning legislation, another Australian research breakthrough is likely to strengthen the case for embryonic stem cell research.

University of New South Wales (UNSW) academics have proven that tumours can be prevented from forming when embryonic stem cells are transplanted.

“Whilst embryonic stem cells have great potential to deliver therapies for disorders, such as diabetes, a fear has been that they will form tumours because of the presence of undifferentiated cells,” said UNSW Professor Bernie Tuch of the Diabetes Transplant Unit, who led the team responsible for the discovery.

“The passing of the legislation in the Senate last night is extremely encouraging,” said Professor Tuch. “Our breakthrough removes what could have been a stumbling block to this vital research.”

... more about:
»Cell »Stem »embryonic stem cell

The team has shown that placing the embryonic cells inside microcapsules made from a product of seaweed, called alginate, prevents the formation of tumours when the encapsulated cells are transplanted into laboratory animals. The team has also shown that the encapsulation process does not stop the embryonic cells from differentiating.

The data describing the experiments has been published in the North American journal Transplantation, the official journal of the international Transplantation Society.

The team used both human and mouse embryonic stem cells to perform their experiments. The human embryonic stem cells were supplied by a member of the team, Chief Hospital Scientist, Dr Kuldip Sidhu, who earlier this year reported producing clones from these stem cells.

The other authors on the paper were Sophia Dean, Yulyana Yulyana and Georgia Williams.

About microencapsulation:

The platform technology of microencapsulation is the same as that which the Diabetes Transplant Unit is using to transplant insulin-producing cells isolated from donor humans into insulin-dependent diabetic people, without using anti-rejection drugs. This Seaweed Diabetes Pilot Trial, which involves 6 people with diabetes, commenced in February this year and is expected to be completed within the next 18 months.

Contact details: Susi Hamilton, UNSW Media unit, 9385 1583 or 0422 934 024

Susi Hamilton | EurekAlert!
Further information:
http://www.unsw.edu.au

Further reports about: Cell Stem embryonic stem cell

More articles from Life Sciences:

nachricht 'Y' a protein unicorn might matter in glaucoma
23.10.2017 | Georgia Institute of Technology

nachricht Microfluidics probe 'cholesterol' of the oil industry
23.10.2017 | Rice University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>